Markers of neck failure in oral cavity and oropharyngeal carcinomas treated with radiotherapy

Citation
A. Fortin et al., Markers of neck failure in oral cavity and oropharyngeal carcinomas treated with radiotherapy, HEAD NECK, 23(2), 2001, pp. 87-93
Citations number
33
Categorie Soggetti
Otolaryngology
Journal title
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
ISSN journal
10433074 → ACNP
Volume
23
Issue
2
Year of publication
2001
Pages
87 - 93
Database
ISI
SICI code
1043-3074(200102)23:2<87:MONFIO>2.0.ZU;2-A
Abstract
Background. Neck management after radiotherapy remains controversial, It is not clear which patients may benefit from postradiotherapy neck dissection . Biologic markers may be useful in this setting. Method. This study includes 81 patients with oral cavity and oropharyngeal carcinomas. The primary tumor had been treated with radical radiotherapy. I mmunohistochemical staining to p53, ki-67, NEU, HSP-27, and GST has been pe rformed. Results. There were 50 T1-2 and 31 T3-4 patients, as well as 36 N0 and 45 N 1-3. A total of 25 nodal failures was observed. With expressed HSP2, 23% of patients had neck failure compared with 51% when HSP-27 was absent (p = .0 2). With NEU overexpression, nodal control decreased from 72% to 34% (p = . 008). In a Cox model, NEU (p = .01) and HSP-27 (p = .05) were associated wi th neck failure. Conclusions. HSP-27 and NEU expression may play a role in predicting nodal failure. This should be confirmed in a larger, prospective study. (C) 2001 John Wiley & Sons, Inc.